Dec 06, 2016 12:04 pm UTC| Business
TACTT3 Phase 3 trial to resume enrollment in early 2017 as previously announced ZUG, Switzerland, Dec. 06, 2016 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics...
Dec 06, 2016 12:01 pm UTC| Business
NEWTOWN, Pa.and SAN JOSE, Calif., Dec. 06, 2016 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer and...
Dec 06, 2016 12:01 pm UTC| Business
NIH’s NIAID completes first cohort of dose selection study Data from completed study expected in first half of 2017Upon determining the optimal dose, a pivotal trial could be conducted to support marketing authorization of...
Dec 06, 2016 12:01 pm UTC| Business
NIH’s NIAID completes first cohort of dose selection study Data from completed study expected in first half of 2017Upon determining the optimal dose, a pivotal trial could be conducted to support marketing authorization of...
Dec 06, 2016 12:00 pm UTC| Business
ZUG, Switzerland, Dec. 06, 2016 -- Auris Medical Holding AG (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today confirmed that...
Dec 06, 2016 12:00 pm UTC| Business
DUBAI, United Arab Emirates, Dec. 06, 2016 -- According to a recent EY report, despite current global uncertainties regarding growth prospects the longer-term outlook for economic growth and investment in Africa remains...
Mitek to Participate in 5th Annual ROTH Utah Corporate Access Event
Dec 06, 2016 12:00 pm UTC| Business
SAN DIEGO, Dec. 06, 2016 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that James DeBello, Chairman and CEO, and Russ...